5-Methylcytidine (m5C)-modified circSMAD2 promotes pancreatic cancer progression via the AKT/mTOR pathway

Read full text Summarise with VIRAT
Authors: Zehui Zhang, Wenchang Li, Yi Zhao, Shuyu Zhai, Da Fu, Jiewei Lin, Xinjing Wang
Cited by: 0
References: 53

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Circular RNAs (circRNAs) are increasingly recognized as critical regulators in carcinogenesis through diverse molecular mechanisms. In this study, we reported an NSUN2-mediated methyl-5-cytosine (m5C)-dependent circSMAD2 that was significant upregulation in pancreatic cancer tissues and correlated with poor clinical outcomes. Functional analyses demonstrated that circSMAD2 overexpression promoted tumor growth in both in vitro and in vivo xenograft models. Mechanistically, cytoplasmic circSMAD2 functions as a competitive endogenous RNA by sequestering miR- 769 - 5 p, thereby relieving its repression of TRIM59 and subsequently activating the oncogenic AKT/mTOR signaling pathway. Concurrently, circSMAD2 acted as a scaffold for the interaction between IGF2BP1 and TPT1 , facilitating IGF2BP1-mediated N6-methyladenosine (m6A) modification of TPT1 , which further amplified AKT/mTOR pathway activation. The synergistic dual-axis activation of AKT/mTOR signaling through m5C-driven ceRNA activity and m6A-mediated posttranscriptional regulation collectively contributed to pancreatic cancer progression. Our findings establish circSMAD2 as a pivotal oncogenic driver in pancreatic cancer and highlight its potential as a diagnostic biomarker and therapeutic target for precision oncology interventions.

Fields of Study & Subjects

Circular RNAs in diseases RNA modifications and cancer Cancer-related molecular mechanisms research

Publication details

Journal / source
Genes & Diseases
Pages
102156–102156
Publication date
1 March 2026
Language
EN